October 23, 2025
1 min read

Lonza’s recently purchased Calif. biologics site plays key role in sales rebound

The company expects sales in the second half of the year to outpace those from the first and reiterated its annual revenue guidance, projecting growth between 20% and 21% for all of 2025.

Leave a Reply

Your email address will not be published.

Previous Story

Natalie Christensen: Committed to excellence in student and athlete nutrition at ISU

Next Story

Integrating Nutrition and Lifestyle Strategies in Pediatric Multiple Sclerosis Management | NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Previous Story

Natalie Christensen: Committed to excellence in student and athlete nutrition at ISU

Next Story

Integrating Nutrition and Lifestyle Strategies in Pediatric Multiple Sclerosis Management | NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop